Mabion S.A.

🎉 Celebrating Success and Excellence at Mabion! 🎉   On December 13th, we had the pleasure of witnessing two incredible events that highlight the talent and spirit of Mabion’s team. 👨🏫 Graduation of the Leadership Academy Congratulations to all the participants of the Leadership Academy, which has been running since March 2024! This intensive program aimed to empower our leaders with new skills and knowledge. We are so proud of your growth and achievements 🎓✨ Congratulations to our graduates:   🔹Paulina Budzińska 🔹Piotr Ciesielski 🔹Paulina Konderak 🔹Marlena Kozłowska 🔹Izabela Kuskowska 🔹Anna Moskal 🔹Paweł Nurkiewicz 🔹Weronika Rabij 👏 Your dedication and hard work inspire us all.   🏆 Golden Flask Awards 2024 This year marked the 3rd edition of our internal competition, in which employees can appreciate their colleagues for professional excellence and the unique contributions they bring to Mabion’s culture. The Golden Flask Awards 2024 go to:   MabSmile: Marta Bednarek MabWoman: Izabela Kuskowska MabMan: Karol Malek MabBrain: Wiktor Pszczółkowski Thank you to everyone who participated, nominated, and voted. You are the heartbeat of our company. ❤️   At Mabion, we celebrate growth, leadership, and the collaborative spirit that drives our success. Let’s continue to build a future full of innovation and inspiration together!   #LeadershipAcademy #GoldenFlaskAwards #TeamMabion #GrowthAndExcellence

The Power of SPR at Mabion At Mabion, we define innovation as the relentless pursuit of new tools and knowledge that expand our capabilities and deliver state-of-the-art services in the CDMO world. From the beginning, our Research and Development Department has been at the forefront of this mission, exemplified by our use of the Surface Plasmon Resonance (SPR) technique. SPR is a standout among Ligand Binding Assays (LBA), providing confident and reliable analyses of biomolecular interactions. Whether it’s the quantification of proteins or the evaluation of kinetic and affinity parameters, SPR delivers precise, real-time results without the need for additional labels or detection reagents - saving time, reducing costs, and simplifying workflows. The method operates on the concept of total internal reflection, detecting changes in the refractive index caused by molecular binding on the surface of a sensor chip. These changes generate a response curve, known as a sensorgram, which provides a detailed graphical representation of the interaction dynamics. Depending on the research needs, SPR enables, among others, the following types of analysis: ➡️ Kinetic Analysis: To measure the dynamics of molecular interactions (association and dissociation events). ➡️ Affinity Analysis: To determine the strength of these interactions. ➡️ In the biopharmaceutical industry, SPR assays are often run in a head-to-head (H2H) format, enabling the comparison of test samples against reference samples for precise relative values. As a company committed to quality and compliance, all our SPR studies are conducted in a regulated environment, adhering to 21 CFR Part 11 FDA standards. This ensures reliability and reproducibility in every step of the process. Through the continuous adoption of modern technologies like SPR, Mabion maintains high scientific standards in its offerings and strengthens its dedication to biopharmaceutical innovation. #Mabion #CDMO #SPR #Biopharma #Innovation #Analytics #RnD

🌍 Exciting News from Mabion! 🌍 We’re thrilled to announce that Mabion will once again be attending the Biotech Showcase in San Francisco this January! 🎉 This prestigious event is a cornerstone for connecting with investors and industry leaders in the biotech and life sciences sectors. With over 400 presenting companies and an impressive USD 400 billion in capital represented, it’s the perfect platform for Mabion to strengthen our position and forge new partnerships in the US market. Representing Mabion at the event will be: 💡 Adam Pietruszkiewicz, Chief Commercial Officer 💡 Marty Henehan, VP of Business Development – Head of North America We’re looking forward to meaningful discussions and opportunities to drive innovation in the biotech space. Check out the Biotech Showcase website for more details about this incredible event. Let’s make 2025 a year of impactful collaborations! 💪 #BiotechShowcase #LifeSciences #CDMO #Innovation #Partnership 

🌟 Exciting news from Mabion! We proudly participated in the #Tech4Life 2024 conference in Łódź, where innovation took center stage 🚀 As a pioneering Biologics CDMO, we believe innovation drives progress. It’s how we achieve our sustainability goals—minimizing waste, streamlining processes, and maintaining uncompromising quality. Leveraging advanced analytics, including our proprietary bioassay methods, we deliver precise, reliable results that redefine excellence in drug development. Organized by Invest in Lodz (Central Poland), the Tech4Life conference gathered visionary leaders, cutting-edge innovators, and technology enthusiasts to explore the future of life sciences. Our very own Marketing Specialist, Jakub Knurek, showcased how Mabion integrates state-of-the-art technologies into our service portfolio, ensuring we remain at the forefront of biologics manufacturing and development. Beyond the spotlight, we seized the opportunity to build regional partnerships and align emerging technologies with the dynamic needs of the biopharmaceutical sector. These collaborations reaffirm Mabion’s commitment to providing our partners with high-quality, efficient, and innovative solutions that keep us ahead in the evolving biologics CDMO landscape. 💡 What role do you think technology will play in shaping the future of biologics? Share your thoughts in the comments! #Mabion #Biopharma #Innovation #Technology #Sustainability #Biologics

🌍 The intensive development of the economy, 🌾agriculture, the burning of fossil fuels, and unsustainable consumption are the factors responsible for the increased emissions of greenhouse gases, which have consequently led to rapid climate change. These changes have triggered 📜 legislative processes within the EU, and climate transformation is now one of the European Council's top priorities. The European Climate Law sets a binding climate target for the EU: to reduce net greenhouse gas emissions by at least 📉 55% by 2030 compared to 1990 levels and to achieve 🌟climate neutrality by 2050. This climate target mobilizes businesses to adopt responsible practices and implement ♻️ environmentally friendly solutions. However, it also poses a considerable challenge, including for Mabion. The enactment of the ESG strategy for 2024-2027 marked the first step toward achieving 🌏 sustainability goals in line with the Paris Agreement. Over the past few months, we have led a project at Mabion that developed a long-term decarbonization strategy. Thanks to the support of 🤝external experts and the commitment of the Mabion working team, it was possible to conduct an energy efficiency audit and identify potential solutions for reducing greenhouse gas emissions for Scope 1 and 2. #ESG #decarbonization #carbonfootprint

🌟Celebrating the Power of Mentorship in Leadership Development🌟 Last week marked the culmination of the Leadership Academy 3.0 program with a truly inspiring mentoring module. Together with mentors from Mabion and external experts, our participants explored vital leadership themes: ✅ Leadership by Example  ✅ Change Management  ✅ Effective Communication  ✅ Collaboration & Multigenerational Team Management  ✅ Learning from Mistakes  ✅ Developing Team Members  ✅ Best Practices for Team Success The session provided a unique opportunity to: 🔹 Strengthen leadership skills cultivated throughout the year-long program. 🔹 Gain fresh perspectives from diverse industries and organizations. 🔹 Recognize that leadership challenges—and solutions—are universal. Most importantly, it reinforced a key message: the mentorship and experience of senior Mabion leaders are available every day, empowering our leadership community to grow together and achieve excellence. A heartfelt thank you to our mentors for sharing their wisdom and to our participants for their enthusiasm and dedication to becoming stronger, more effective leaders: Anna Glinska, Błażej Bębenista, MBA, Przemysław Fabjanowski, Amanda Jabłońska, Paulina Toboła, Mateusz Dobrowolski, Paweł Pobiedziński  – THANK YOU! Let’s keep building a culture of collaboration, learning, and growth! 🚀 #Leadership #Mentorship #AcademyOfLeaders #TeamDevelopment #ContinuousLearning #Mabion

Breaking Boundaries in Innovation and Global Collaboration! 🌍🚀 At Mabion, innovation isn’t just a buzzword – it’s the driving force behind everything we do. As a world-class CDMO in the biopharmaceutical industry, we are proud to be part of a growing number of Polish companies making waves on the global stage. In a special feature by TVP World, we opened our doors to showcase our groundbreaking work in biopharmaceuticals, focusing on our commitment to innovation and international partnerships 🌐💡 From our cutting-edge production facilities to our state-of-the-art laboratories, the film crew captured the pulse of our daily operations. We had the pleasure of sharing our story through interviews with two of our leaders: Julita Balcerek, PhD, MBA, IPMA C (COO) and Anna Czubatka-Bieńkowska, PhD (Project Management Division Manager). The piece delves into how our team works tirelessly to drive forward quality and effectiveness of our CDMO offer, pushing the boundaries of what's possible in global healthcare 🌱💉 What truly sets Mabion apart is not just our innovation, but our ability to connect and collaborate on the international market. Our commitment to expanding beyond borders is reflected in our strong partnerships across the globe. Stay tuned for this exciting feature, as we continue to innovate and deliver on our mission to improve lives worldwide. #Mabion #Innovation #Biopharma #GlobalPartnerships #CDMO

🔬 Ion Exchange Chromatography in Monoclonal Antibodies Purification 🧬   Ion-exchange chromatography (IEX) is a key technique used in protein purification and charge heterogeneity analysis, widely applied in the biopharmaceutical sector for the development and production of protein therapies. This technique enables the efficient removal of impurities, such as host cell proteins (HCPs) and aggregates, while maintaining the appropriate isoform profile, which is crucial for ensuring product safety and efficacy.   IEX is particularly valued for its wide range of applications, ease of scalability, cost-effectiveness, and high-throughput potential. The separation process relies on interactions between charged proteins and the oppositely charged stationary phase, utilizing the amphoteric properties of proteins, which allow separation based on their net charge at specific pH values.   This article provides a detailed discussion on various types of ion-exchange chromatography, their areas of application, and key factors for ensuring optimal method performance. The authors are our top experts in this area: ➡️ Małgorzata Urbaniak, Senior Specialist in Physicochemical Analytical Methods ➡️ Piotr Miłek, Specialist in Physicochemical Analytical Methods ➡️ Anna Morawska, Junior Downstream Process Specialist   🔗 Want to learn more? Click here https://lnkd.in/dC6k8MwM   #IEX #chromatography #Mabion #CDMO #downstream #processing #protein #purification

Movember 2024: Let's Take Care of Men's Health!   November 19 is a special occasion to talk about men’s health – it’s International Men’s Day. At Mabion S.A., we emphasize the importance of prevention and early diagnostics, proudly supporting the Movember campaign.   Do you know why men grow mustaches in November? Mustaches have become a symbol of this campaign, combining seriousness with a fun and engaging approach to spark conversations about health.   👉 Campaign goal: to change the approach to prevention, diagnosis, and treatment of male cancers. 👉 What can we do? Encourage men to undergo regular check-ups, talk about potential symptoms, and support access to genetic testing.   Statistics show that there is still much to do to raise awareness of male cancers. At Mabion, we support health and life every day, but this November, with mustaches on our faces, we are making our voices heard even louder 😊   Grow a mustache. Start a conversation. Act for health.   #Movember #Cancer #Prevention #Awareness #Mabion

🌍 #GlobalBiosimilarsWeek showcased the transformative potential of biosimilars in making healthcare more accessible 💉   At Mabion S.A., we deeply understand the challenges faced by biosimilar companies—after all, we were one of them not so long ago. Today, we specialize in advanced biologics manufacturing, combining extensive expertise with cutting-edge technologies to deliver consistently high-quality products to our partners. As industry leaders, we share our insights and offer outsourcing solutions tailored to:   ✅ Advanced cGMP Biological Manufacturing ✅ Seamless Scale-Up in Bioreactors of Various Capacities ✅ Comprehensive Process Development (CLD, USP, DSP) ✅ Full Analytical Panel & QP/QC Release Testing ✅ Vial Fill & Finish Services   🔗 Learn more at https://lnkd.in/derFHp5e and explore our dedicated solutions for biosimilars. At Mabion, our customers always come first.   The science behind biosimilars is as fascinating as it is rigorous. From precise characterization of reference biologics to optimizing manufacturing processes and conducting robust clinical trials, every step ensures biosimilars match the safety and efficacy of their reference products. Today, more than 1,000 approved biosimilars are transforming lives globally—and this is just the beginning 📈   💡 A big thank you to IGBA - International Generic and Biosimilar medicines Association and all participants for driving innovation in pharma. Together, we are shaping a future where advanced therapies and medicines (ATMPs) are accessible to everyone.   #Mabion #CDMO #Biosimilars #GMP #Development #Manufacturing #Quality #Analytics #Comparability #Biopharma